Literature DB >> 33150962

Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Idanna Innocenti1, Federica Sora1,2, Francesco Autore1, Patrizia Chiusolo1,2, Sabrina Giammarco1, Elisabetta Metafuni1, Andrea Bacigalupo1,2, Simona Sica1,2, Luca Laurenti1,2.   

Abstract

Entities:  

Keywords:  CLL; allogeneic transplant; ibrutinib

Year:  2020        PMID: 33150962     DOI: 10.1002/hon.2826

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  1 in total

1.  Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation.

Authors:  Tomohiko Tanigawa; Masatoshi Sakurai; Jun Kato; Kota Mizuno; Shinya Fujita; Yuya Koda; Taku Kikuchi; Takayuki Shimizu; Shinichiro Okamoto; Keisuke Kataoka
Journal:  Ann Hematol       Date:  2021-07-08       Impact factor: 3.673

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.